94
Views
4
CrossRef citations to date
0
Altmetric
Review

New targets in the treatment of anorexia nervosa

, &
Pages 135-151 | Published online: 22 Apr 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kristine J Steffen, James L Roerig, James E Mitchell & Saritha Uppala. (2006) Emerging drugs for eating disorder treatment. Expert Opinion on Emerging Drugs 11:2, pages 315-336.
Read now

Articles from other publishers (3)

Kristine J. Steffen, James E. Mitchell, James L. Roerig & Kathryn L. Lancaster. (2007) The eating disorders medicine cabinet revisited: A clinician's guide to ipecac and laxatives. International Journal of Eating Disorders 40:4, pages 360-368.
Crossref
Frank M Theisen, Michael Haberhausen, Eberhard Schulz, Christian Fleischhaker, Hans-Willi Clement, Monika Heinzel-Gutenbrunner & Helmut Remschmidt. (2006) Serum Levels of Olanzapine and Its N-desmethyl and 2-hydroxymethyl Metabolites in Child and Adolescent Psychiatric Disorders: Effects of Dose, Diagnosis, Age, Sex, Smoking, and Comedication. Therapeutic Drug Monitoring 28:6, pages 750-759.
Crossref
Stephanie SantelThomas F. MünteKerstin KrauelMichael RotteLioba Baving. (2006) Neuropsychologische Beeinträchtigungen und kognitive Verarbeitung von Essensreizen bei Anorexia nervosa. Zeitschrift für Neuropsychologie 17:4, pages 239-248.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.